TrialPsychopharmacology2021

Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.

Richard J Zeifman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.